Get startedLog in
    Picture of Kyorin Pharmaceutical Co logo

    4569 — Kyorin Pharmaceutical Co Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Kyorin Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line8,2558,3525,2166,9067,019
    Depreciation
    Non-Cash Items-363-2,432405-1,483-1,285
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-3,435-4,297-2,988-7,339-8,507
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Taxes Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities7,6785,1876,3471,9241,517
    Capital Expenditures-3,217-5,124-2,690-9,405-6,246
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items2748651303,1303,059
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-2,943-4,259-2,560-6,275-3,187
    Financing Cash Flow Items-1-1-2-1-1
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-5,117-4,918-4,112-3,363-3,347
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-404-4,033-186-7,473-4,930